Seminal papers in urology: maintenance Bacillus Calmette-Guerin (BCG) immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized southwest oncology group study (SWOG-8507). [PDF]
BMC Urol, 2023 Tempo J, Bolton D, O'Callaghan M.
europepmc +1 more source
Radiolabelled choline and FDG PET/CT: two alternatives for the assessment of lymph node metastases in patients with upper urinary tract urothelial carcinoma [PDF]
, 2015 Evangelista, Laura +3 more
core +1 more source
Combating VEGFA‐siRNA‐Induced Metabolic Reprogramming via Glucose Utilization Deprivation
Advanced Science, EarlyView.An ionizable lipid nanoparticle co‐delivers VEGFA siRNA and glucose oxidase to tumors to counteract VEGFA knockdown‐induced, glutamine‐driven metabolic compensation. Enzymatic glucose consumption reverses the adaptive pathways and restores metabolism toward baseline, thereby sensitizing tumors to therapy.
Lulu Zheng +10 more
wiley +1 more source
Identification of Biomarkers Related to Prognosis of Bladder Transitional Cell Carcinoma. [PDF]
Front Genet, 2021 Liu Z +6 more
europepmc +1 more source
Advanced Science, EarlyView.Fluorescent BODIPY‐conjugated thiosemicarbazone ligands and their Ga(III), In(III), and Fe(III) complexes, inspired by Triapine, are developed as theranostic agents. Multiphoton FLIM and confocal microscopy in cancer cells and zebrafish reveal real‐time uptake, mitochondrial localisation, and whilst spectroscopic assays indicated preserved complex ...
Megan J. Green +15 more
wiley +1 more source
Musculo-Invasive Urachal Transitional Cell Carcinoma (TCC): Is It Really Sinister and Different? [PDF]
CureusRaghavendran M +4 more
europepmc +1 more source
Renal Cell Carcinoma Mimicking Transitional Cell Carcinoma: A Case Report. [PDF]
Am J Case Rep, 2021 Irama W, Teo JK, Wong KM.
europepmc +1 more source
Intra-individual Comparative Study of Dynamic and Pharmacocavernography [PDF]
, 1989 Sommerkamp, H. +2 more
core +1 more source
O‐GlcNAcylated TAP1 Impairs Antigen Presentation and Promotes Immune Evasion in Bladder Cancer
Advanced Science, EarlyView.This article unveils a critical mechanism of immune evasion in bladder cancer, which the O‐GlcNAc modification of TAP1 disrupts antigen presentation. This modification triggers HLA‐A degradation, shielding tumor cells from CD8+ T cell attack. The findings highlight targeting this pathway as a promising therapeutic avenue to sensitize tumors to ...
Jinpeng Wu +10 more
wiley +1 more source
Research on the prognosis of different types of microvessels in bladder transitional cell carcinoma. [PDF]
World J Clin Cases, 2021 Wang HB, Qin Y, Yang JY.
europepmc +1 more source